Defects in Signal Transduction and Disease — MCQs
If there is a Gs alpha subunit gain-of-function mutation, this results in
Which of the following is a genetic disorder that does not primarily affect ion channels?
What is the primary function of G-proteins in cellular signaling?
The gene most commonly involved in endometrial carcinoma is:
G-protein coupled receptor that does not act through opening of potassium channels is:
In the mitogen activated protein kinase pathway, the activation of RAS is counteracted by
Which of the following stimulate adenylate cyclase with G-protein coupled action ?
Phospholipid associated with the mechanism of hormone action is
Which of the following binds to Tyrosine Kinase receptor?
Which of the following statements about G protein-coupled receptors (GPCRs) is true?
Defects in Signal Transduction and Disease Indian Medical PG Practice Questions and MCQs
Question 1: If there is a Gs alpha subunit gain-of-function mutation, this results in
- A. Increased cAMP (Correct Answer)
- B. Decreased cAMP
- C. Increased GTPase activity
- D. Decreased IP₃
Explanation: ***Increased cAMP*** - A **gain-of-function mutation** in the **Gs alpha subunit** means it remains in its active, GTP-bound state for longer. - The activated Gs alpha subunit stimulates **adenylyl cyclase**, leading to persistently high levels of **cAMP**. *Decreased cAMP* - This would result from a **loss-of-function** mutation in the Gs alpha subunit or a gain-of-function in an inhibitory G protein (Gi), not a Gs gain-of-function. - A decrease in cAMP would inhibit downstream signaling pathways, which is the opposite of what occurs with Gs activation. *Increased GTPase activity* - **GTPase activity** is responsible for hydrolyzing GTP to GDP, which inactivates the G alpha subunit. - A gain-of-function mutation often implies **reduced GTPase activity**, causing the G protein to stay active longer, not increased activity. *Decreased IP* - **IP3 (inositol trisphosphate)** is a secondary messenger produced via the activation of **phospholipase C**, typically by Gq proteins. - Gs alpha subunit mutations primarily affect the **adenylyl cyclase/cAMP pathway**, not the inositol phosphate pathway.
Question 2: Which of the following is a genetic disorder that does not primarily affect ion channels?
- A. Cystic fibrosis
- B. Liddle's syndrome
- C. Hypokalemic periodic paralysis
- D. Tay-Sachs disease (Correct Answer)
Explanation: ***Cystic fibrosis*** - Primarily caused by mutations in the **CFTR gene**, which encodes a **chloride channel**, but it is not classified as a classic channelopathy. - The disease mainly affects **mucus production** rather than direct dysfunction of ion channels in the traditional sense. [1] *Hypokalemic periodic paralysis* - This condition is directly related to **ion channel dysfunction**, specifically affecting **sodium channels** in muscle cells. - It causes episodic **muscle weakness** and hypokalemia due to improper ion transport. *Liddle's syndrome* - A genetic disorder resulting from mutations affecting **epithelial sodium channels**, leading to **hypertension**. - It exemplifies classic channelopathy by causing dysregulation of sodium reabsorption in the kidneys. *Tay-sach's disease* - A ***gangliosidosis*** caused by a deficiency in the enzyme **Hexosaminidase A**, rather than ion channel dysfunction. - It results in the accumulation of **GM2 gangliosides** leading to neurological degeneration, not affecting ion channels directly. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 120-122.
Question 3: What is the primary function of G-proteins in cellular signaling?
- A. Signal transducers (Correct Answer)
- B. Mediators of hormone action
- C. Molecules that bind hormones
- D. Intracellular signaling molecules
Explanation: ***Signal transducers*** - G-proteins act as **molecular switches**, converting extracellular signals received by G protein-coupled receptors (GPCRs) into intracellular responses. - They bind **GTP** in their active state and **hydrolyze it to GDP** to become inactive, regulating downstream effectors like enzymes and ion channels. *Mediators of hormone action* - While G-proteins are involved in the action of many hormones, this describes a *result* of their function rather than their fundamental role. - Their primary function is to transduce signals, which then mediates hormone effects. *Molecules that bind hormones* - **Receptors**, not G-proteins, are primarily responsible for binding hormones or other ligands. - G-proteins are activated *after* a receptor binds a ligand and undergoes a conformational change. *Intracellular signaling molecules* - This statement is true, but it's a broad category. **Signal transducers** specifically highlights their role in converting one form of signal to another. - Many molecules operate intracellularly, but G-proteins' unique role is in linking receptor activation to effector modulation.
Question 4: The gene most commonly involved in endometrial carcinoma is:
- A. PTEN (Correct Answer)
- B. BRAF
- C. KRAS
- D. Mismatch repair genes
Explanation: ***PTEN*** - **PTEN** (phosphatase and tensin homolog) is a **tumor suppressor gene** frequently inactivated in **endometrial carcinoma**, particularly in cases of **endometrioid histology**. - Loss of PTEN function leads to uncontrolled cell proliferation and survival by activating the **PI3K/Akt signaling pathway**, contributing to tumor development. *BRAF* - **BRAF mutations** are most commonly associated with **melanoma** and certain types of **thyroid cancer**, specifically papillary thyroid carcinoma. - While BRAF mutations can be found in a small subset of other cancers, they are not a primary driver or common gene in endometrial carcinoma. *KRAS* - **KRAS mutations** are frequently observed in **colorectal cancer**, **pancreatic cancer**, and **non-small cell lung cancer**. - Though KRAS can be mutated in various cancers, it is not the most commonly involved gene in endometrial carcinoma. *Mismatch repair genes* - Mutations in **mismatch repair (MMR) genes** (e.g., MLH1, MSH2, MSH6, PMS2) are characteristic of **Lynch syndrome** and lead to **microsatellite instability (MSI)**. - While MSI is observed in a significant subset of endometrial cancers (especially those associated with Lynch syndrome), PTEN mutations are more broadly common across all types of endometrial carcinoma.
Question 5: G-protein coupled receptor that does not act through opening of potassium channels is:
- A. Dopamine D2 receptor
- B. Muscarinic M2 receptor
- C. Serotonin 5 HT 1 receptor
- D. Angiotensin 1 receptor (Correct Answer)
Explanation: ***Angiotensin 1 receptor*** - The **angiotensin 1 receptor (AT1R)** is a **Gq-coupled receptor** that primarily activates the **phospholipase C (PLC)** pathway, leading to increased intracellular **calcium** and **IP3/DAG** signaling. - Its activation mediates vasoconstriction, aldosterone release, and cardiac hypertrophy, none of which involve direct opening of potassium channels. *Dopamine D2 receptor* - **Dopamine D2 receptors** are **Gi/o-coupled receptors** that inhibit adenylyl cyclase and **open potassium channels**, leading to **hyperpolarization** and reduced neuronal excitability. - This action contributes to its **antipsychotic** and **motor control** effects. *Muscarinic M2 receptor* - **Muscarinic M2 receptors** are **Gi/o-coupled receptors** found in the heart that cause **bradycardia** by activating **acetylcholine-gated inwardly rectifying potassium (GIRK) channels**, leading to hyperpolarization. - They also inhibit adenylyl cyclase, reducing cAMP levels and decreasing heart rate and contractility. *Serotonin 5 HT 1 receptor* - **Serotonin 5-HT1 receptors** (e.g., 5-HT1A) are **Gi/o-coupled receptors** that, upon activation, **increase potassium conductance** (hyperpolarization) and inhibit adenylyl cyclase. - This leads to a reduction in neuronal firing and is implicated in the anxiolytic and antidepressant effects of these receptors.
Question 6: In the mitogen activated protein kinase pathway, the activation of RAS is counteracted by
- A. Inositol triphosphate
- B. GTPase activating protein (Correct Answer)
- C. Phosphatidyl inositol
- D. Protein kinase C
Explanation: ***GTPase activating protein*** - **GTPase Activating Proteins (GAPs)** facilitate the hydrolysis of **GTP bound to RAS** to GDP, converting active RAS back to its inactive state. - This inactivation is crucial for turning off the downstream signaling of the **MAPK pathway** and preventing uncontrolled cell proliferation. *Inositol triphosphate* - **Inositol triphosphate (IP3)** is a secondary messenger that triggers the release of **intracellular calcium** from the endoplasmic reticulum. - It is involved in various signaling pathways, but its primary role is not to directly counteract RAS activation. *Phosphatidyl inositol* - **Phosphatidylinositol (PI)** is a component of cell membranes and can be phosphorylated to produce various **phosphatidylinositol phosphates (PIPs)**, like **PIP2** and **PIP3**. - These molecules act as docking sites for signaling proteins but do not directly inactivate RAS. *Protein kinase C* - **Protein kinase C (PKC)** is a family of enzymes involved in signal transduction, typically activated by **diacylglycerol (DAG)** and calcium. - It phosphorylates various proteins, mediating diverse cellular responses, but it does not directly counteract the activation of RAS.
Question 7: Which of the following stimulate adenylate cyclase with G-protein coupled action ?
- A. Shiga toxin
- B. Cholera toxin (Correct Answer)
- C. Diphtheria toxin
- D. Pseudomonas toxin
Explanation: ***Cholera toxin*** - Cholera toxin is a **G-protein-activating toxin** that irreversibly activates **adenylate cyclase**. - This leads to increased intracellular levels of **cAMP**, causing excessive fluid secretion into the intestinal lumen and severe diarrhea. *Shiga toxin* - Shiga toxin acts by inactivating the **60S ribosomal subunit**, thereby inhibiting protein synthesis in eukaryotic cells. - Its primary effect is **cytotoxicity**, not direct stimulation of adenylate cyclase. *Diphtheria toxin* - Diphtheria toxin inhibits **protein synthesis** by inactivating **elongation factor-2 (EF-2)** through ADP-ribosylation. - This toxin specifically targets host cells, leading to cellular death and tissue damage. *Pseudomonas toxin* - **Exotoxin A** produced by *Pseudomonas aeruginosa* also inhibits **protein synthesis** by ADP-ribosylating and inactivating **EF-2**, similar to diphtheria toxin. - It does not directly affect adenylate cyclase activity.
Question 8: Phospholipid associated with the mechanism of hormone action is
- A. Phosphatidylcholine
- B. Phosphatidylethanolamine
- C. Plasmalogen
- D. Phosphatidylinositol (Correct Answer)
Explanation: ***Phosphatidylinositol*** (Correct) - **Phosphatidylinositol (PI)** and its phosphorylated derivatives, particularly **PIP2 (phosphatidylinositol 4,5-bisphosphate)**, are critical in signal transduction pathways activated by many hormones. - Hormones binding to **G protein-coupled receptors** can activate phospholipase C, which cleaves PIP2 into **inositol triphosphate (IP3)** and **diacylglycerol (DAG)**, leading to increased intracellular calcium and protein kinase C activation, respectively. *Phosphatidylcholine* (Incorrect) - **Phosphatidylcholine** is a major component of cell membranes and is involved in membrane structure and fluidity. - While it can be a source of signaling molecules like **lysophosphatidic acid**, it is not primarily associated with the initial intracellular signaling events of hormone action in the same way as phosphatidylinositol. *Phosphatidylethanolamine* (Incorrect) - **Phosphatidylethanolamine** is another abundant membrane phospholipid primarily involved in membrane structure and stability. - It can be a precursor for other lipids, but it does not directly participate in the **second messenger systems** triggered by most hormones as a primary signaling molecule. *Plasmalogen* (Incorrect) - **Plasmalogens** are a unique class of phospholipids containing an ether bond at the sn-1 position. - They are abundant in certain tissues, particularly nervous and cardiovascular tissues, and are thought to have antioxidant properties, but they are not directly involved in the initiating events of **hormone signaling pathways**.
Question 9: Which of the following binds to Tyrosine Kinase receptor?
- A. Insulin (Correct Answer)
- B. Glucagon
- C. Prolactin
- D. Growth Hormone
Explanation: ***Insulin*** - **Insulin** is a classic example of a hormone that binds to and activates a **tyrosine kinase receptor**, leading to a cascade of intracellular signaling events for glucose uptake and metabolism. - The **insulin receptor** is a heterodimeric protein with intrinsic tyrosine kinase activity that phosphorylates itself and other proteins upon insulin binding. *Glucagon* - **Glucagon** primarily acts on **G protein-coupled receptors (GPCRs)**, specifically the glucagon receptor, to increase cyclic AMP (cAMP) and activate protein kinase A. - Its main roles are to stimulate **glycogenolysis** and **gluconeogenesis** in the liver. *Prolactin* - **Prolactin** binds to a receptor that is a member of the **cytokine receptor superfamily**, which lacks intrinsic enzyme activity. - Upon ligand binding, these receptors associate with and activate **Janus kinases (JAKs)**, leading to the JAK-STAT signaling pathway. *Growth Hormone* - **Growth hormone (GH)** also binds to a receptor belonging to the **cytokine receptor superfamily** (similar to prolactin), which then associates with and activates **JAKs**. - This activation subsequently initiates the **JAK-STAT signaling pathway**, mediating its diverse growth-promoting and metabolic effects.
Question 10: Which of the following statements about G protein-coupled receptors (GPCRs) is true?
- A. The three subunits alpha, beta, and gamma must remain together as a complex for G protein to function.
- B. G proteins can act as either inhibitory or excitatory based on the type of alpha subunit. (Correct Answer)
- C. G proteins bind directly to hormones to become activated.
- D. In the resting state, G proteins are bound to GTP.
Explanation: ***G proteins can act as either inhibitory or excitatory based on the type of alpha subunit.*** - Different classes of Gα subunits (e.g., **Gαs**, **Gαi**, **Gαq**) couple to diverse downstream effectors, leading to either **stimulation** (excitatory) or **inhibition** of cellular processes. - For example, **Gαs** activates adenylyl cyclase, while **Gαi** inhibits it, demonstrating their opposing roles. *The three subunits alpha, beta, and gamma must remain together as a complex for G protein to function.* - Upon activation, the **Gα subunit dissociates** from the **Gβγ dimer**, and both free units can then independently modulate effector molecules. - For the G protein to function in signal transduction, the α subunit often separates from the βγ dimer to interact with its target enzyme or ion channel. *G proteins bind directly to hormones to become activated.* - **GPCRs** (the receptors themselves) bind to hormones or other ligands on the **extracellular side** of the membrane. - The binding of the ligand to the GPCR induces a conformational change in the receptor, which then activates the associated G protein on the intracellular side. *In the resting state, G proteins are bound to GTP.* - In the **resting (inactive) state**, the Gα subunit of the trimeric G protein is bound to **GDP**. - Activation occurs when the GPCR facilitates the exchange of **GDP for GTP** on the Gα subunit.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free